Baseline
Track disclosed holdings with the standard reporting lag and no active reweighting.
AI Summary
Defensive, health-care-heavy portfolio with solid absolute returns but persistent underperformance versus SPY.
Portfolio Snapshot
Current optimized weights for the selected default session.
| Symbol | Name | Sector | Weight | Diff |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Health Care | 14.57% | 0 |
| JNJ | Johnson & Johnson | Health Care | 10.34% | 0 |
| ABBV | AbbVie Inc. | Health Care | 6.91% | 0 |
| UNH | UnitedHealth Group Incorporated | Health Care | 6.67% | 0 |
| MRK | Merck & Co., Inc. | Health Care | 5.36% | 0 |
| AMGN | Amgen Inc. | Health Care | 3.46% | 0 |
| TMO | Thermo Fisher Scientific Inc. | Health Care | 3.39% | 0 |
| GILD | Gilead Sciences, Inc. | Health Care | 3.16% | 0 |
| ISRG | Intuitive Surgical, Inc. | Health Care | 3.10% | 0 |
| ABT | Abbott Laboratories | Health Care | 2.84% | 0 |
| PFE | Pfizer Inc. | Health Care | 2.83% | 0 |
| CVS | CVS Health Corporation | Health Care | 2.23% | 0 |
| BMY | Bristol-Myers Squibb Company | Health Care | 2.22% | 0 |
| VRTX | Vertex Pharmaceuticals Incorporated | Health Care | 2.12% | 0 |
| DHR | Danaher Corporation | Health Care | 2.09% | 0 |
| SYK | Stryker Corporation | Health Care | 1.91% | 0 |
| MDT | Medtronic plc | Health Care | 1.89% | 0 |
| MCK | McKesson Corporation | Health Care | 1.75% | 0 |
| ELV | Elevance Health, Inc. | Health Care | 1.62% | 0 |
| BSX | Boston Scientific Corporation | Health Care | 1.55% | 0 |
Sector Exposure
- Health Care100.00%
Weight Changes
Notable position adjustments in the latest snapshot.
Performance vs Benchmark
Strategy NAV vs benchmark — hover for exact values.
Alpha Trend
Excess return vs benchmark over time.
Drawdown Trend
Underwater curve and peak drawdown marker.
Turnover Trend
Per-period turnover with average reference.
Strategy Comparison
All four default strategies side-by-side.
| Strategy | Annualized | Alpha | Sharpe | Max DD |
|---|---|---|---|---|
| Baseline | 8.14% | -1.49% | 0.56 | -28.55% |
| Momentum Screen | 5.74% | -3.21% | 0.40 | -26.41% |
| Basic Value Screen | 6.92% | -2.01% | 0.45 | -38.07% |
| Combo Equal Screen | 10.42% | -1.06% | 0.58 | -30.54% |
Recent Periods
Per-period performance vs benchmark.
| Period | Strategy | Benchmark | Excess | Turnover | Trades |
|---|---|---|---|---|---|
| 2025-05-31 | 1.24% | 3.75% | -2.50 | 0.77 | 60 |
| 2025-06-30 | -0.69% | 2.69% | -3.38 | 0.92 | 60 |
| 2025-07-31 | 5.19% | 2.05% | +3.14 | 1.67 | 60 |
| 2025-08-31 | -0.88% | 3.66% | -4.54 | 1.44 | 60 |
| 2025-09-30 | 3.58% | 2.05% | +1.53 | 2.29 | 60 |
| 2025-10-31 | 9.49% | 0.20% | +9.29 | 1.72 | 60 |
| 2025-11-30 | 0.55% | 0.99% | -0.44 | 1.90 | 60 |
| 2025-12-31 | -0.18% | 1.47% | -1.65 | 0.72 | 60 |
| 2026-01-31 | 2.79% | -1.35% | +4.14 | 1.51 | 60 |
| 2026-02-28 | -9.10% | -7.93% | -1.18 | 1.60 | 60 |
| 2026-03-31 | -2.66% | 9.42% | -12.08 | 1.22 | 60 |
| 2026-04-30 | 0.26% | 4.11% | -3.85 | 3.79 | 58 |
Strategy Q&A
Pre-generated questions and answers about this strategy.
- baseline13FChat AI
Which holdings or sectors dominate the baseline risk profile?
Concentration is the first item to inspect: top 5 43.85%, top 10 59.80%, top 20 80.01%. The largest names are LLY (Eli Lilly and Company) 14.57%, JNJ (Johnson & Johnson) 10.34%, ABBV (AbbVie Inc.) 6.91%, UNH (UnitedHealth Group Incorporated) 6.67%, and MRK (Merck & Co., Inc.) 5.36%, and the largest sector exposures are Health Care 100.00%. If those exposures reverse, baseline performance can diverge sharply from a broad index.
strategyViews.baseline.concentrationstrategyViews.baseline.sectorWeights↳ Show the top holdings, sector weights, and concentration metrics for the latest disclosed period.
- baseline13FChat AI
Which recent periods best explain the baseline risk-return trade-off?
The strongest recent period was 2025-10-31 (9.49% strategy return, 0.20% benchmark, 9.29% excess, 1.72% turnover), while the weakest was 2026-03-31 (-2.66% strategy return, 9.42% benchmark, -12.08% excess, 1.22% turnover). Those periods should be read alongside baseline metrics of return 8.14%, alpha -1.49%, beta 0.72, Sharpe 0.56, Sortino 0.74, and max drawdown -28.55% to judge whether returns came from persistent exposure or a narrow timing window.
strategyViews.baseline.periodPerformancestrategyViews.baseline.metrics↳ Show the worst drawdown windows and the top holdings active during those periods.
- baseline13FChat AI
What does directly following XLV | S&P 500 Health Care Sector ETF expose an investor to as of 2026-04-30?
The baseline is a direct read-through of the disclosed ETF or index-like fund. It is led by LLY (Eli Lilly and Company) 14.57%, JNJ (Johnson & Johnson) 10.34%, and ABBV (AbbVie Inc.) 6.91%, with sector exposure of Health Care 100.00%. The baseline metrics show return 8.14%, alpha -1.49%, beta 0.72, Sharpe 0.56, Sortino 0.74, and max drawdown -28.55%, so this should be treated as an equity exposure with its own concentration and timing risk rather than a neutral benchmark clone.
fund.holdingsAsOfstrategyViews.baseline.topHoldingsstrategyViews.baseline.metrics↳ Compare the baseline holdings with the benchmark sector weights and identify the largest active risks.
Other strategies for this fund
Momentum Screen
Select holdings by historically observable momentum, targeting roughly one quarter of each period's original member count and no more than 20 names; when a period has over 100 members, pre-rank to the top 50 first.
Basic Value Screen
Select holdings using PE, PB, P/FCF, and EV/EBITDA, targeting roughly one quarter of each period's original member count and no more than 20 names; when a period has over 100 members, pre-rank to the top 50 first.
Combo Equal Screen
Filter for large-cap, quality, and low-leverage holdings, rank by composite quality/value/size score, keep the top 20 names, and equal-weight the selected names.